Biotech China 2014
Current Trends in Leukemia, Lymphoma, and Myeloma
The Westin Pasadena
191 N. Los Robles Ave.
Pasadena, California
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/673/id/5/conference_id/673
   Speakers
   --------

   Ann F. Mohrbacher, Wen-Kai Weng

   Overview and Purpose
   This symposium is designed to update medical oncologists/hematologists
   and other health care professionals on potentially practice-changing
   data on the treatment of leukemia, lymphoma, and myeloma presented at
   recent international hematology/oncology meetings. Participants will
   have the opportunity to learn about these advances through
   presentations by national and regional experts, interactive case
   discussions, and question-and-answer opportunities, with the overall
   goal of integrating these advances into clinical practice as well as
   enhancing awareness of novel agents in development. Furthermore, the
   most important data will be presented in the form of a poster session,
   for which ample time will be allocated for viewing. These features
   will reinforce the key data and allow participants to see and hear the
   information in multiple formats. This program will thus provide an
   invaluable and timely opportunity for practicing
   oncologists/hematologists to increase their knowledge base and improve
   their performance in managing their patients. These meetings will also
   foster networking opportunities for community practitioners.

   New for 2011: Poster session featuring top abstracts from ASH 2010!
   Target Audience This educational activity is directed toward medical,
   surgical, and radiation oncologists interested in the treatment of
   patients with hematologic malignancies. Fellows, nurse practitioners,
   nurses, physician assistants, pharmacists, researchers, and other
   health care professionals interested in the treatment of hematologic
   malignancies are also invited to attend. Learning Objective At the
   conclusion of this symposium, you should be able to: Discuss and
   debate emerging data on and recent advances in the treatment of
   patients with hematologic malignancies and integrate key findings into
   clinical practice


   191 N. Los Robles Ave., Pasadena, CA , 91101, United States

   Loading (May not complete on browsers without Javascript support)...

   Try again

Schedule of Presentations:

Saturday, February 26, 2011
07:30:00 Registration and Continental Breakfast
07:45:00 Poster Session
08:05:00 Welcome Introductions and Presession Survey Ann F. Mohrbacher
08:10:00 Lymphoma
08:15:00 Management of Aggressive Lymphoma Ann F. Mohrbacher
08:45:00 New Insights on Low-Grade NHL Ann F. Mohrbacher
09:15:00 Panel/Case-Based Discussion
09:45:00 Break
09:55:00 Myeloma
10:00:00 Progress in Multiple Myeloma Robert Vescio
10:30:00 Question-and-Answer Session/Case-Based Discussion
10:55:00 Myeloid Malignancies
11:00:00 Emerging Agents for MDS and AML
11:30:00 Postsession Survey and Case-Based Discussion
12:00:00 Lunch
12:25:00 Benign Hematologic Disorders
12:30:00 Poster Session
13:00:00 Presession Survey
13:10:00 Update on Novel Therapies for ITP and Other Benign Hematologic Disorders Ilene Weitz
13:40:00 Question-and-Answer Session/Case-Based Discussion
13:55:00 Leukemia
14:00:00 What's New in the Management of CLL? Steven Coutre
14:30:00 Update on CML and Other Myeloproliferative Neoplasms Michael W.N. Deininger
15:00:00 Postsession Survey and Panel/Case-Based Discussion
15:20:00 Concluding Remarks | Top 5 Take-Home Messages From the Chair
15:30:00 Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.